Efficacy Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Patients

Update Il y a 4 ans
Reference: NCT00615264

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

The purpose of this study is to determine if DiaPep277 can effectively protect the internal production of insulin in patients newly diagnosed with type 1 diabetes, by stopping the immune destruction of insulin-producing beta-cells in the pancreas. DiaPep277 acts on the immune system and is expected to prevent further destruction of the beta-cells by stimulating regulatory responses, without causing immunological suppression.


Inclusion criteria

  • Type 1 Diabetes